Composition
- Active ingredients
- PANCRELIPASE (AMYLASE 24,600USP UNITS; LIPASE 4,200USP UNITS; PROTEASE) 14,200USP UNITS
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- PANCRELIPASE (AMYLASE 149,900USP UNITS; LIPASE 37,000USP UNITS; PROTEASE) 97,300USP UNITS · Capsule, delayed releaseBLA022523-005 · Prescription
- PANCRELIPASE (AMYLASE 98,400USP UNITS; LIPASE 16,800USP UNITS; PROTEASE) 56,800USP UNITS · Capsule, delayed releaseBLA022523-003 · Prescription
- PANCRELIPASE (AMYLASE 24,600USP UNITS; LIPASE 4,200USP UNITS; PROTEASE) 14,200USP UNITS · Capsule, delayed releaseThis page
- PANCRELIPASE (AMYLASE 15,200USP UNITS; LIPASE 2,600USP UNITS; PROTEASE) 8,800USP UNITS · Capsule, delayed releaseBLA022523-006 · Prescription
- PANCRELIPASE (AMYLASE 83,900USP UNITS; LIPASE 21,000USP UNITS; PROTEASE) 54,700USP UNITS · Capsule, delayed releaseBLA022523-004 · Prescription
- PANCRELIPASE (AMYLASE 61,500USP UNITS; LIPASE 10,500USP UNITS; PROTEASE) 35,500USP UNITS · Capsule, delayed releaseBLA022523-002 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application BLA022523.



